SignatureFD’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

SignatureFD’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-33	Closed	-$22	–	3344
2024 Q2	$22	Hold	33	–	–	﹤0.01%	3092
2024 Q1	$20	Hold	33	–	–	﹤0.01%	3144
2023 Q4	$19	Hold	33	–	–	﹤0.01%	3107
2023 Q3	$22	Hold	33	–	–	﹤0.01%	3169
2023 Q2	$109	Hold	33	–	–	﹤0.01%	3174
2023 Q1	$303	Hold	33	–	–	﹤0.01%	3147
2022 Q4	$391	Hold	33	–	–	﹤0.01%	3133
2022 Q3	$1K	Hold	33	–	–	﹤0.01%	3064
2022 Q2	$1K	Sell	33 -74	-69%	-$2.52K	﹤0.01%	3050
2022 Q1	$5K	Buy	+107	New	+$5.29K	﹤0.01%	2534
2021 Q4	–	Sell	-6	Closed	-$1K	–	3310
2021 Q3	$1K	Buy	+6	New	+$570	﹤0.01%	2968

SignatureFD's VBIV Position: Q3 2024 in Review

SignatureFD sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 33 shares — an estimated $22 sold.

SignatureFD first reported a position in VBIV in Q3 2021 and held it in 11 quarters. The position peaked at $5K in Q1 2022. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.

SignatureFD reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
SignatureFD sold 33 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $22.
SignatureFD first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2021 and held it in 11 quarters.
SignatureFD's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $5K in Q1 2022.
1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.

Based on SignatureFD's 13F filing for Q3 2024, filed 21 Oct 2024.